Beta Drugs Limited (NSE:BETA)
1,696.15
-19.95 (-1.16%)
At close: Mar 10, 2025
Beta Drugs Company Description
Beta Drugs Limited develops, manufactures, and sells anti-cancer drugs in India.
The company offers oncology products in the areas of breast, lung, head and neck, colorectal, ovarian, gastric, testicular, renal, and prostate cancer, as well as brain tumor, leukemia, lymphoma, myeloma, and supportive cancer; and dermatology products.
It also develops active pharmaceutical ingredients. The company exports its products.
Beta Drugs Limited was incorporated in 2005 and is based in Panchkula, India.
Beta Drugs Limited
Country | India |
Founded | 2005 |
Industry | Biological Products, Except Diagnostic Substances |
Employees | 371 |
Contact Details
Address: SCO-184 Panchkula, Himachal Pradesh 134114 India | |
Phone | 91 17 2258 5481 |
Website | betadrugslimited.com |
Stock Details
Ticker Symbol | BETA |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
SIC Code | 2836 |